 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | International Pharmaceutical Federation (FIP) |
| Street 1: | Andries Bickerweg 5 |
| Street 2: | |
| City: | The Hague |
| Province: | |
| Post Code: | 2517JP |
| Country: | Netherlands |
| Phone: | +33703021970 |
| Organization Email: | fip@fip.org |
| Web Site: | http://www.fip.org |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Developed Country NGO |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Non-Governmental Organization |
| Organization Type - Secondary: | Other Non-Governmental Organization (NGO) |
| Organization Description: | |
| 1. about your organization Founded in 1912, the International Pharmaceutical Federation (FIP) is the global federation of national associations of pharmacists and pharmaceutical scientists in official relations with the World Health Organization (WHO). Through its 122 Member Organisations and 4000 Individual Members, FIP represents and serves almost two million practitioners and scientists around the world. Throughout its almost 100 year history, FIP's priorities have expanded both literally and figuratively to meet the needs and expectations of the profession in expanding healthcare services and integrating emerging scientific developments. Changes in pharmacy and the emergence of Pharmacy Practice as a cornerstone of the profession have lead FIP to become globally visible for its advocacy on behalf of the role of the pharmacist in the provision of healthcare, while still maintaining its grounding in the pharmaceutical sciences. In parallel, the membership of FIP has evolved to become the most extensive global pharmacy and pharmaceutical sciences network. This network is continuing to expand its presence and influence through partnerships with some of the world’s leading healthcare, educational and scientific institutions. FIP’s mission is to improve global health by advancing pharmacy practice and science to enable better discovery, development, access to and safe use of appropriate, cost-effective, quality medicines worldwide. 2. why you are interested in tuberculosis Engaging all health care providers as a part of strengthening health systems to ensure delivery of quality-assured TB care is an essential component of the Stop TB Strategy. In many countries, pharmacists are the frontline health care providers and often a first point of contact for people with symptoms of TB. Evidence suggests that pharmacists constitute an important and essential health work-force and have a great potential to contribute to TB control in a variety of ways including increasing awareness about TB among the l |
|
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Advocacy Delivery of health services and care Technical Assistance |
Other Organization Information | |
| Total number of staff in your organization: | 11 - 25 |
| Number of full-time staff who are directly involved with TB: | 1 - 5 |
| Number of part-time staff who are directly involved with TB: | 1 - 5 |
| Number of volunteers who are directly involved with TB: | 1 - 5 |
| How did you hear about the Stop TB Partnership: | Stop TB communications |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Network with other partners |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | No |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
Geographical Reach | |
| Which country is your headquarters located in: | Netherlands |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Albania Argentina Australia Austria Bangladesh Belgium Benin Brazil Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde China Colombia Congo Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic Democratic People's Republic of Korea Denmark Egypt El Salvador Eritrea Estonia Ethiopia Finland France Gabon Germany Ghana India Indonesia Iraq Ireland Israel Italy Jamaica Japan Jordan Kenya Lebanon Malawi Mexico Mongolia Morocco Mozambique Myanmar Nepal Netherlands Nigeria Paraguay Peru Philippines Portugal Republic of Korea Republic of Moldova Romania Saudi Arabia Senegal Singapore Spain Sri Lanka Sudan Sweden Switzerland Thailand Togo Tunisia Turkey Uganda United Republic of Tanzania United States of America Uruguay Viet Nam Zambia Zimbabwe |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: Support national pharmacy professional and student associations in scaling up training and other interventions to promote role of pharmacists as DOTS provider. In 2011, we are funding 12 country projects with various objectives relating to DOTS expansion and enhancement. |
|
Declaration | |
| Declaration of interests: No conflict of interest at all | |
| Application date: | October 11, 2010 |
| Last updated: | July 25, 2013 |